Skip to content

Prevention of Alcohol and Tabacco Consumption Using Interventions Based on Mindfulness in Boys with Mild to Borderline Intellectual Disabilities (MBID)

Prevention of Alcohol and Tabacco Consumption Using Interventions Based on Mindfulness in Boys with Mild to Borderline Intellectual Disabilities (MBID) - IMAC-Mind_TP5

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00014042
Enrollment
120
Registered
2018-03-19
Start date
2020-04-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DROGENPREVENTION Prevention of alcohol and tobacco consumption

Interventions

Group 1: Experimental intervention: After demonstrating the feasibility of mindfulness-based interventions (MBI) for the at-risk group of adolescents with Mild to Borderline Intellectual Disabilities

Sponsors

Universitätsmedizin Rostock, Klinik für Psychiatrie, Neurologie, Psychosomatik und Psychotherapie im Kindes- und Jugendalter
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
11 Years to 17 Years

Inclusion criteria

Inclusion criteria: (1) Adolescent boys (2) Age: 11-17 yrs. (3) MBID (70 = IQ = 85) (4) who report drinking alcohol during the past year (5) informed consent from participants and one parent/legal guardian

Exclusion criteria

Exclusion criteria: (1) Boys without experiences of drinking (2) severe psychiatric disorders requiring on-site treatment or dependence on alcohol or drugs (3) Profound developmental delays (autism) (4) Severe speech disorder

Design outcomes

Secondary

MeasureTime frame
Secondary endpoints: Substance use data will be correlated with neurobehavioral variables, dispositional mindfulness, and other possible mediating variables (stress, regulation of emotions, mental health, familiy risk factors, influence of peers, personality, intelligence)

Primary

MeasureTime frame
Primary efficacy endpoint: Duration between training and events of drunkenness, frequency/quantity of alcohol use during 12 months after treatment. Primary outcome Alcohol: Comparisons of group differences in survival rates for the event “drunkenness last week” for 12 months after treatment.

Countries

Germany

Contacts

Public ContactLucie Waedel

Universitätsmedizin Rostock, Klinik für Psychiatrie, Neurologie, Psychosomatik und Psychotherapie im Kindes- und Jugendalter

lucie.waedel@med.uni-rostock.de0381 494 9518

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 17, 2026